NCT01301716 2016-11-02
A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid Tumors
Genentech, Inc.
Phase 1 Completed
Genentech, Inc.
Genentech, Inc.